1614P PSA responses and PSMA scan changes after immunotherapy for biochemically recurrent prostate cancer (BCR) without androgen deprivation therapy (ADT)Ravi A. Madan, Fatima Karzai, Chao Chen et al.|Annals of Oncology|2024Cited by 2
Radium 223 without androgen deprivation therapy (ADT) in patients (Pts) with biochemically recurrent prostate cancer (BCR) and PET findings in the bones.Melissa L. Abel, Ravi A. Madan, Fatima Karzai et al.|Journal of Clinical Oncology|2025Cited by 0
Radium 223 without androgen deprivation therapy (ADT) in patients (Pts) with biochemically recurrent prostate cancer (BCR) and PET findings in the bones.Melissa L. Abel, Ravi A. Madan, Fatima Karzai et al.|Journal of Clinical Oncology|2026Cited by 0